The global intraocular lens market size is calculated at USD 4,730 million in 2024 and is predicted to reach around USD 7,490 million by 2034, expanding at a CAGR of 4.7% from 2024 to 2034.
The intraocular lens market refers to the production, distribution, and use of this lens, which is an artificial lens that is implemented in the eye to replace the natural lens at the time of cataract surgery or refractive lens exchange. It is also called IOL, which refers to an artificial lens that is implemented in the eye, usually cataract surgery or other problems. It is implemented in the eye’s lens capsule, where the contraction of the ciliary body, which would focus the eye with the natural lens, is used to focus the implant. There is a high demand for this lens in eye research institutes, ophthalmologic clinics, ambulatory surgical centers, and hospitals, which is driving the growth of the intraocular lens market.
However, the challenging factors of the market include market competition, high initial investment, and regulatory hurdles, which can restrict the growth of the market. The future scope of the market includes technological advancement, patient awareness, the development of new surgical techniques, and reduced costs, which will be an opportunity for the growth of the intraocular lens market.